Global Label-Free Detection Strategic Business Report 2023: Growing Production of Recombinant Therapeutic Proteins to Drive Gains

Dublin, June 20, 2023 (GLOBE NEWSWIRE) -- The "Label-Free Detection: Global Strategic Business Report" report has been added to's offering.

The global market for Label-Free Detection estimated at US$1.1 Billion in the year 2022, is projected to reach a revised size of US$1.9 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2022-2030.

Instruments, one of the segments analyzed in the report, is projected to record 6.3% CAGR and reach US$1.3 Billion by the end of the analysis period.

Taking into account the ongoing post pandemic recovery, growth in the Consumables segment is readjusted to a revised 8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $386 Million, While China is Forecast to Grow at 8.9% CAGR

The Label-Free Detection market in the U.S. is estimated at US$386 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$171.9 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.5% and 6.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.

Select Competitors (Total 41 Featured) -

  • Agilent Technologies, Inc.
  • AMETEK, Inc.
  • Attana AB
  • Corning Inc.
  • Hitachi High-Technologies Corp.
  • Horiba Ltd.
  • Malvern Panalytical Ltd.
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Molecular Devices, LLC
  • GE Healthcare Life Sciences
  • TA Instruments
  • Merck KGaA.

Key Attributes:

Report AttributeDetails
No. of Pages384
Forecast Period2022 - 2030
Estimated Market Value (USD) in 2022$1.1 Billion
Forecasted Market Value (USD) by 2030$1.9 Billion
Compound Annual Growth Rate7.1%
Regions CoveredGlobal

Key Topics Covered:




  • Influencer Market Insights
  • World Market Trajectories
  • Growing Population, Rising Disease Burden, the Need for New Generation Drugs & Rising Pharma R&D, the Cornerstone for Growth in the Market
  • Rising Prevalence of Chronic Diseases Amplifies the Need for Advancing Healthcare Research: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
  • Aging Population Burdens an Already Strained Healthcare System: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Robust Investments in Lifesciences Research to Develop Effective, Safe & Affordable Drugs Spurs Growth in the Pharmaceutical & Biotechnology Sectors
  • Better Insights Offered by Label-Free Detection into Drug Binding Kinetics & Drug Residence Time Drives Demand for this Technology in Drug Discovery: Global Pharma R&D Spending (In US$ Billion) for the Years 2017, 2019, 2022 & 2024
  • Growing Interest in Genomics Research: A Major Win for the Market
  • A Strong Vision for the Future of Genomics Creates Robust Demand for Improved Repertoire of Research Tools: Global Market for Genomics (In US$ Billion) for the Years 2019, 2022, 2024 & 2026
  • A Review of Key Market Segments
  • Label-Free Detection - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession



  • Growing Production of Recombinant Therapeutic Proteins to Drive Gains in the Market
  • The Need to Address Unmet Medical Needs Creates New Opportunities in the Development of Therapeutic Proteins: Global Recombinant Therapeutic Antibodies & Proteins Market (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
  • Expanding Pharmaceutical Contract Research Outsourcing to Drive Growth in Asia-Pacific
  • Rising Cost of Drug Safety Conformance Spurs Interest in Outsourcing Pharmacovigilance to CROs: Global Contract Research Organization Revenue (In US$ Billion) for the Years 2017, 2019, 2021 and 2023 by Geographic Region
  • Growing Market for Biosimilars Expands the Addressable Market Opportunity for Label-Free Detection as an Analytical Tool to Demonstrate Biosimilarity
  • With the Biosimilars Opportunity Ballooning to a Tempting US$4.6 Billion, Growing Research in This Space Entails Greater Use of Label-Free Techniques for Kinetic Evaluation of Monoclonal Antibodies: Global Biosimilars Market (In US$ Million) for the Years 2018, 2020 and 2022
  • Rising Incidence of Food Allergy & the Ensuing Labeling Compliance Drives Interest in Label-Free Detection of Allergens in Food
  • Growing Opportunity in Food Safety Testing Against the Backdrop of Rising Burden of Food Allergy: Global Food Safety Testing Market (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
  • Strong Opportunity For Label Free Detection in Cancer Diagnosis & Characterization
  • Growing Global Burden of Cancer Throws the Spotlight on Unmet Therapy Needs: Global Cancer New Incidence & Number of Deaths (In 0000s) by Type for the Year 2018
  • Supported by the Epidemic Spread of Cancer, the Robustly Growing Cancer Diagnostics Market to Generate Revenue Opportunities for Label-Free Detection: Global Cancer Diagnostics Market (In US$ Billion) for the Years 2017, 2019 & 2022
  • Innovations in Label-Free Detection, Crucial for Long-Term Growth in the Market
  • Emerging New Applications for Label-Free Optical Biosensors Amplifies Revenue Opportunities in the Market




For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Global Market for Label-Free Detection

Contact Data